Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

20K views

Cited by 17

12:55 min

February 16th, 2015

10.3791/52397-v

February 16th, 2015

20K views

The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.

Explore More Videos

CAR T Cells

Chapters in this video

0:05

Title

1:59

Administration of Temozolomide and Whole Brain Irradiation to Tumor-bearing Mice (days 0-4)

3:26

Cell Transfection, Splenectomy, and T Cell Preparation (day 0)

6:09

Transduction (days 1 and 2)

8:10

CAR T Cell and Administration to Tumor-bearing Mice (days 3-5)

10:03

Results: Antitumor Efficacy of CAR T Cells

11:47

Conclusion

Related Videos